Ashleigh Barreto active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Investor Relations Contact | 2021-09-30 | - |
| Public Communications Contact | 2021-09-30 | - |
Career history of Ashleigh Barreto
Former positions of Ashleigh Barreto
| Companies | Position | Start | End |
|---|---|---|---|
| ADAMAS PHARMACEUTICALS, INC. | Investor Relations Contact | - | 2018-11-30 |
| Public Communications Contact | - | 2018-11-30 | |
| XOMA CORPORATION | Investor Relations Contact | - | - |
Statistics
International
| United States | 4 |
Operational
| Investor Relations Contact | 3 |
| Public Communications Contact | 2 |
Sectoral
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| XOMA CORPORATION | Health Technology |
| VIRACTA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
- Stock Market
- Insiders
- Ashleigh Barreto
- Experience
